Sugi Predict

Sugi Predict / Compounds / SCHEMBL11997510

SCHEMBL11997510

SCHEMBL11997510

CCCC(=O)NC1[C@H](OCCC(c2ccccc2)c2ccccc2)OC(CO)[C@@H](O[C@H]2C[C@H](O)[C@@H](O[C@@H]3OC(CO)[C@@H](O[C@H]4C[C@H](O)[C@H](O[C@@H]5OC(COS(=O)(=O)O)[C@@H](O[C@H]6C[C@H](O)[C@H](O[C@H]7OC(COS(=O)(=O)O)[C@@H](O[C@H]8C[C@H](O)[C@H](O)CO8)[C@H](O)C7NC(=O)CCC)CO6)[C@H](O)C5NC(=O)CCC)CO4)[C@H](O)C3NC(=O)CCC)CO2)[C@@H]1O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ BMP2 P12643 1/20 0.32
▸ VEGFA P15692 1/20 0.32
▸ CXCL12 P48061 1/20 0.32
▸ SHH Q15465 1/20 0.32
▸ TLR4 O00206 1/20 0.31
▸ LGALS3 P17931 4/20 0.31
▸ LGALS1 P09382 1/20 0.31
▸ LGALS7; LGALS7B P47929 1/20 0.31
▸ LGALS8 O00214 1/20 0.31
▸ LGALS4 P56470 1/20 0.31
▸ B4GALT1 P15291 1/20 0.31
▸ SLC6A2 P23975 1/20 0.30
▸ BDNF P23560 3/20 0.30
▸ PTN P21246 2/20 0.30
▸ MDK P21741 2/20 0.30
▸ HPSE Q9Y251 3/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11997506 0.90 LGALS3 (0.35) CA1CA2CA9BMP2VEGFA
SCHEMBL11997507 0.87 SELL (0.32) BMP2VEGFACXCL12SHHTLR4
SCHEMBL11997494 0.86 VEGFA (0.43) BMP2VEGFACXCL12SHHTLR4
SCHEMBL11997495 0.83 VEGFA (0.43) BMP2VEGFACXCL12SHHTLR4
SCHEMBL11997509 0.83 BMP2 (0.33) BMP2VEGFACXCL12SHHLGALS3
SCHEMBL11997511 0.83 LGALS3 (0.35) BMP2VEGFACXCL12SHHLGALS3
SCHEMBL11997498 0.79 BDNF (0.42) BMP2VEGFACXCL12SHHLGALS3
SCHEMBL11997493 0.79 VEGFA (0.50) BMP2VEGFACXCL12SHHLGALS3
SCHEMBL11997497 0.78 VEGFA (0.49) BMP2VEGFACXCL12SHHLGALS3
SCHEMBL11997503 0.78 CD69 (0.40) BMP2VEGFACXCL12SHHLGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012413-B2 FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof SANOFI (FR) 2015-04-21 — — US disclosed
US-20120214754-A1 FGF RECEPTOR-ACTIVATING N-ACYL OCTASACCHARIDES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214754-A1 FGF RECEPTOR-ACTIVATING N-ACYL OCTASACCHARIDES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF FGFR1, FGF2, FGFR3 CA1 1957/4885CA2 1736/4885CA9 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback